Heitmar R, Varma C, De P, Lau Y C, Blann A D
Aston University, School of Life and Health Sciences, Aston Triangle, B4 7ET, Birmingham, UK.
Department of Cardiology, City Hospital, Birmingham, B18 7QH, UK.
Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2257-2265. doi: 10.1007/s00417-016-3432-9. Epub 2016 Jul 20.
To test the hypothesis of a significant relationship between systemic markers of renal and vascular function (processes linked to cardiovascular disease and its development) and retinal microvascular function in diabetes and/or cardiovascular disease.
Ocular microcirculatory function was measured in 116 patients with diabetes and/or cardiovascular disease using static and continuous retinal vessel responses to three cycles of flickering light. Endothelial function was evaluated by von Willebrand factor (vWf), endothelial microparticles and soluble E selectin, renal function by serum creatinine, creatinine clearance and estimated glomerular filtration rate (eGFR). HbA1c was used as a control index.
Central retinal vein equivalence and venous maximum dilation to flicker were linked to HbA1c (both p < 0.05). Arterial reaction time was linked to serum creatinine (p = 0.036) and eGFR (p = 0.039); venous reaction time was linked to creatinine clearance (p = 0.018). Creatinine clearance and eGFR were linked to arterial maximum dilatation (p < 0.001 and p = 0.003, respectively) and the dilatation amplitude (p = 0.038 and p = 0.048, respectively) responses in the third flicker cycle. Of venous responses to the first flicker cycle, HbA1c was linked to the maximum dilation response (p = 0.004) and dilatation amplitude (p = 0.017), vWf was linked to the maximum constriction response (p = 0.016), and creatinine clearance to the baseline diameter fluctuation (p = 0.029). In the second flicker cycle, dilatation amplitude was linked to serum creatinine (p = 0.022).
Several retinal blood vessel responses to flickering light are linked to glycaemia and renal function, but only one index is linked to endothelial function. Renal function must be considered when interpreting retinal vessel responses.
验证在糖尿病和/或心血管疾病中,肾脏和血管功能的全身标志物(与心血管疾病及其发展相关的过程)与视网膜微血管功能之间存在显著关联这一假设。
使用对三个闪烁光周期的静态和连续视网膜血管反应,测量了116例糖尿病和/或心血管疾病患者的眼部微循环功能。通过血管性血友病因子(vWf)、内皮微粒和可溶性E选择素评估内皮功能,通过血清肌酐、肌酐清除率和估计肾小球滤过率(eGFR)评估肾功能。糖化血红蛋白(HbA1c)用作对照指标。
视网膜中央静脉等效值和静脉对闪烁的最大扩张与HbA1c相关(均p < 0.05)。动脉反应时间与血清肌酐(p = 0.036)和eGFR(p = 0.039)相关;静脉反应时间与肌酐清除率(p = 0.018)相关。肌酐清除率和eGFR与第三次闪烁周期中的动脉最大扩张(分别为p < 0.001和p = 0.003)和扩张幅度(分别为p = 0.038和p = 0.048)反应相关。在第一次闪烁周期的静脉反应中,HbA1c与最大扩张反应(p = 0.004)和扩张幅度(p = 0.017)相关,vWf与最大收缩反应(p = 0.016)相关,肌酐清除率与基线直径波动(p = 0.029)相关。在第二次闪烁周期中,扩张幅度与血清肌酐相关(p = 0.022)。
视网膜血管对闪烁光的几种反应与血糖和肾功能相关,但只有一个指标与内皮功能相关。在解释视网膜血管反应时必须考虑肾功能。